These results propose a possible therapeutic approach to atherosclerosis linked cardiovascular diseases: genetic inhibition of IDO leading to reduced 3-HK and, consequently, diminished ROS production could be a feasible way of avoiding endothelial cell loss. This evidence concerns the gene IDO1 and atherosclerosis.